MedPath

JM-010

Generic Name
JM-010

Open-Label Extension Study of ASTORIA

Phase 2
Terminated
Conditions
Dyskinesias
Interventions
First Posted Date
2022-08-26
Last Posted Date
2024-10-14
Lead Sponsor
Contera Pharma A/S
Target Recruit Count
6
Registration Number
NCT05516875
Locations
🇮🇹

Contera Investigational site_IT, Roma, Italy

🇪🇸

Contera Investigational site_ES, Madrid, Spain

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Phase 2
Completed
Conditions
Levodopa Induced Dyskinesia (LID)
Parkinson's Disease
Interventions
Drug: Placebo
First Posted Date
2015-05-08
Last Posted Date
2016-01-13
Lead Sponsor
Bukwang Pharmaceutical
Target Recruit Count
30
Registration Number
NCT02439203
© Copyright 2025. All Rights Reserved by MedPath